CYP3A5 and colonic neoplasm: Moreover, we show that LS180 colon cancer cells that overexpress SXR are less sensitive to CPT-11 treatment compared to control cells, indicating that this transcription factor is involved in drug resistance, probably through CYP3A4, CYP3A5, MDR1 and MRP1 upregulation.